NowRx

Neutral
BETA

Technology-driven, on-demand pharmacy providing free, same-day delivery

Analytics

Raised to Date: $20,002,878

Aggregate Commitments $
Platform

SeedInvest

Start Date

08/14/2019

Close Date

06/19/2020

Min. Goal

$1,500,000

Max. Goal

$20,000,001

Min. Investment

$1,000

Security Type

Equity - Preferred

Funding Type

RegA+

Valuation

$65,000,000

Weekly Commitments $
Status
Funded
Reporting Date

07/05/2020

Days Remaining
Funded
% of Min. Goal

1,334%

% of Max. Goal

100%

Likelihood of Max
Funded
Avg. Daily Raise

$64,525

Momentum
Funded
Location
Industry

Healthcare & Pharmaceuticals

Tech Sector

NowRx, with a pre-money valuation of $65 million, is raising funds on SeedInvest through Reg A+ crowdfunding. It is a pharmacy delivery solution that uses advanced technology to provide free same-day delivery for all prescription needs. The on-demand delivery model of NowRx offers convenience, higher worker productivity, and superior customer experience. NowRx was founded by Cary Breese and Sumeet Shoekand and has raised over $10 million in previous rounds of financing. The current funding round has a minimum target of $1,500,000 and a maximum target of $20,000,001, and the funds will be used for marketing and sales, R&D and technology development, and expansion. NowRx has reported 1064% customer growth since 2016 and a 30% revenue run rate growth in five months.

Balance Sheet

Cash and Cash Equivalents

$4,253,065

Investment Securities

$0

Total Investments

$0

Accounts and Notes Receivable

$356,316

Loans

$0

Property, Plant and Equipment (PP&E)

$383,553

Property and Equipment

$0

Total Assets

$5,681,761

Accounts Payable & Accrued Liabilities

$589,495

Policy Liabilities and Accruals

$0

Deposits

$0

Long Term Debt

$0

Total Liabilities

$589,495

Total Stockholders' Equity

$5,092,266

Total Liabilities and Equity

$5,681,761

Statement of Comprehensive Income Information

Total Revenues

$4,743,075

Total Interest Income

$0

Costs & Expenses Applicable to Rev

$-4,108,233

Total Interest Expenses

$0

Depreciation and Amortization

$30,945

Net Income

$-3,000,901

Earnings Per Share - Basic

$-1

Earnings Per Share - Diluted

$-1

Auditor: Fruci & Associates II, PLLC

Analyst Report

Neutral
Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.
Other Deals

UpLyft on Wefunder

UpLyft has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
HealtheMed on Wefunder

HealtheMed has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…

Crowd
Millennial Fertility Co. on NetCapital

The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add NowRx on SeedInvest
Follow company
Follow NowRx on SeedInvest